Inhibition of monkey brain semicarbazide-sensitive amine oxidase by various antidepressants

Neuroscience Letters

Volumn 286, Issue 2, 2000, Pages 131-133

  Obata, Toshio ^a   Yamanaka, Yasumitsu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Antidepressant; Benzylamine; Monkey brain; Semicarbazide; Semicarbazide sensitive amine oxidase

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); BENZYLAMINE; IMIPRAMINE; MAPROTILINE; NOMIFENSINE; ZIMELDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DEAMINATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL;

ADRENERGIC UPTAKE INHIBITORS; AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIPRAMINE; MACACA; MALE; MAPROTILINE; NEURONS; NOMIFENSINE; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; ZIMELDINE;

EID: 0034595748     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01087-9     Document Type: Article

References (14)

1. Andree T.H., Clark D.E. Characteristics and specificity of phenelzine and benseraside as inhibitors of benzylamine oxidase and monoamine oxidase. Biochem. Pharmacol. 30:1981;959-965.
2. Clarke D.E., Lyles G.A., Callingham B.A. A comparison of cardiac and vascular clorgyline-resistant amine oxidase and monoamine oxidase. Inhibition by amphetamine, mexiletine and other drugs. Biochem. Pharmacol. 31:1982;27-35.
3. Coppen A. Indoleamines and affective disorders. J. Psychiatry Res. 9:1972;163-171.
4. Deng Y., Yu P.H. Assessment of the deamination of aminoacetone, an endogenous substrate for semicarbazide-sensitive amine oxidase. Anal. Biochem. 270:1999;97-102.
5. Dostert P. Myth and reality of the classical MAO inhibitors: reasons for seeking a new generation. Tipton M.F., Dostert P., Strolin Benedetti M. Monoamine Oxidsase and Disease. 1984;9-24 Academic Press, New York.
6. Kinemuchi H., Morikawa F., Ueda T., Arai Y. Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. I. Inhibition by a selective monoamine oxidase-B inhibitor, MD 780236. Jpn. J. Pharmacol. 41:1986;183-189.
7. Lizcano Fernandez J.M., de Arriba A., Tipton K.F., Unzeta M. Inhibition of bovine lung semicarbazide-sensitive amine oxidase (SSAO) by some hydrazine derivatives. Biochem. Pharmacol. 52:1993;187-195.
8. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
9. Lyles G.A. The interaction of semicarbazide-sensitive amine oxidase with MAO inhibitors. Tipton K.F., Dostert P., Strolin-Benedetti M. Monoamine Oxidase and Disease. 1984;547-556 Academic Press, New York.
10. Neff N.H., Yang H-Y.T. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs. Life Sci. 14:1974;2061-2074.
11. Owens M.J., Ieni J.R., Knight D.L., Winders K., Nemeroff C.B. The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies. Life Sci. 57:1995;373-380.
12. Prakash C., Cui D. Metabolism and excretion of a new antianxiety drug candidate. CP-93, 393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Drug Metab. Dispos. 25:1997;1395-1406.
13. Prange A.J. Jr., Wilson I.C., Lynn C.W., Alltop L.B., Stikeleather R.A. L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders. Arch. Gen. Psychiatry. 30:1974;56-62.
14. Yu P.H., Tipton K.F. Deuterium isotope effect of phenelzine on the inhibition of rat liver mitochondrial monoamine oxidase activity. Biochem. Pharmacol. 38:1989;4245-4251.